| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2008 | EP1942886A1 New crystalline form of perindopril erbumine |
| 07/16/2008 | EP1942885A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 07/16/2008 | EP1942884A2 Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
| 07/16/2008 | EP1942883A2 Topical anesthetic for dental procedures |
| 07/16/2008 | EP1942882A2 Combination of histone deacetylase inhibitors and radiation |
| 07/16/2008 | EP1942881A2 Compositions and methods for treatment of renal failure |
| 07/16/2008 | EP1942880A1 A combination of cannabinoids for the treatment of peripheral neurophatic pain |
| 07/16/2008 | EP1942879A1 Gaba receptor mediated modulation of neurogenesis |
| 07/16/2008 | EP1942736A2 Hiv integrase inhibitors |
| 07/16/2008 | EP1942734A2 Preparation of aprepitant |
| 07/16/2008 | EP1942733A2 Radiolabeled glycine transporter inhibitors |
| 07/16/2008 | EP1942732A2 Certain chemical entities, compositions, and methods |
| 07/16/2008 | EP1830840B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2008 | EP1799232A4 Self-gelling alginate systems and uses thereof |
| 07/16/2008 | EP1763356B1 Composition comprising a survivin antisense oligonucleotide and gemcitabine for the treatment of cancer |
| 07/16/2008 | EP1709044B1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/16/2008 | EP1689737B1 Beta-lactams for the treatment of cns disorders |
| 07/16/2008 | EP1660093B1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 07/16/2008 | EP1660067B1 Methods and materials for treating conditions associated with metabolic disorders |
| 07/16/2008 | EP1651240A4 Method for increasing breast meat yield in poultry |
| 07/16/2008 | EP1641801B1 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 07/16/2008 | EP1635837B1 (3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer |
| 07/16/2008 | EP1620439B1 New polymorphs of olanzapine hydrochloride |
| 07/16/2008 | EP1608655B1 Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them, and their use as nootropic agents |
| 07/16/2008 | EP1603577B1 Compounds for the treatment of pain |
| 07/16/2008 | EP1583532B1 Quinoline derivatives as glucokinase ligands |
| 07/16/2008 | EP1581492B1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 07/16/2008 | EP1581194B1 Multilayered tablet containing pravastatin and aspirin and method |
| 07/16/2008 | EP1556376B1 Large conductance calcium-activated k channel opener |
| 07/16/2008 | EP1554316B1 Lignan complexes |
| 07/16/2008 | EP1534245B1 Rapidly disintegrating tablet |
| 07/16/2008 | EP1529025B1 Polyisoprenylbenzophenone derivatives, method for production and use thereof |
| 07/16/2008 | EP1517890B1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1499325B1 Composition comprising trehalose and zinc and use thereof to inhibit skin irritation |
| 07/16/2008 | EP1492500B1 Formoterol and ciclesonide aerosol formulations |
| 07/16/2008 | EP1485160B1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 07/16/2008 | EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1461032B1 Use of c-kit inhibitors for promoting hair growth |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1426051B1 Medicinal composition for prevention of or treatment for cerebrovascular disorder |
| 07/16/2008 | EP1414431B1 AMINO-ACID-BASED therapeutic COMPOSITIONS, FOR THE HEALING AND/OR MENDING OF WOUNDS AND LESIONS, IN PARTICULAR IN THE OPHTHALMIC FIELD |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1390491B1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors |
| 07/16/2008 | EP1390372B1 1-oxa-3,9-diaza-spiro'5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/16/2008 | EP1386913B1 Pyrrole derivative |
| 07/16/2008 | EP1337270B1 Long-acting interferon and interlukin derivatives and pharmaceutical compositions comprising them |
| 07/16/2008 | EP1326849B1 Benzodiazepine derivatives as inhibitors of gamma secretase |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
| 07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
| 07/16/2008 | EP1292674B1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 07/16/2008 | EP1286966B1 4-aminopiperidine derivatives and their use as medicine |
| 07/16/2008 | EP1280534B1 Torasemide-containing storage stable pharmaceutical preparations |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1200108B1 Use of ginkgo extract for treating cancer which is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 07/16/2008 | EP1178789B1 Method of treating eating disorders |
| 07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 07/16/2008 | EP1124550B1 Uses and compositions for selective cancer chemotherapy |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | EP1082134B1 Use of haptenised tumour cells and extracts thereof |
| 07/16/2008 | EP1073654B1 2,3-olefinic epothilone derivatives |
| 07/16/2008 | EP1061070B1 Process for the preparation of ED-71 |
| 07/16/2008 | EP1054004B1 Novel pyrimidine-5-carboxamide derivatives |
| 07/16/2008 | EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/16/2008 | EP1012277B1 Syndecan interacting proteins and the use thereof |
| 07/16/2008 | EP0983072B2 Use of inulin for the manufacture of a medicament for the prevention and treatment of colon cancer |
| 07/16/2008 | EP0840599B1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 07/16/2008 | EP0630246B1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 07/16/2008 | CN101223443A Method for evaluating the effects of smoke on bronchioles |
| 07/16/2008 | CN101223269A Compositions and methods for treating tissue |
| 07/16/2008 | CN101223185A Compounds useful for treating neurodegenerative disorders |
| 07/16/2008 | CN101223184A Glucuronidated nebivolol metabolites |
| 07/16/2008 | CN101223182A Cyclodextrin inclusion complexes and methods of preparing same |
| 07/16/2008 | CN101223179A Biologically active compounds obtainable from sorangium cellulosum |
| 07/16/2008 | CN101223178A Therapeutic agents |
| 07/16/2008 | CN101223175A Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP |
| 07/16/2008 | CN101223174A New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against UV radiation |
| 07/16/2008 | CN101223171A Pharmacokinetically improved compounds |
| 07/16/2008 | CN101223170A 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of TPL2 kinase and methods of making and using the same |
| 07/16/2008 | CN101223169A Pyrrole(2,3-b)pyridine derivatives protein kinase inhibitors |
| 07/16/2008 | CN101223167A Novel heteroaryl fused cyclic amines |
| 07/16/2008 | CN101223165A Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 07/16/2008 | CN101223164A Substituted piperidines as renin inhibitors |
| 07/16/2008 | CN101223163A New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 07/16/2008 | CN101223162A Indolylmaleimide derivatives |
| 07/16/2008 | CN101223160A Benzoimidazole compound capable of inhibiting prostaglandin D synthetase |
| 07/16/2008 | CN101223158A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 07/16/2008 | CN101223153A Dibenzocycloheptane compounds and pharmaceuticals containingthese compounds |
| 07/16/2008 | CN101223151A 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 07/16/2008 | CN101223150A Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 07/16/2008 | CN101223147A Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 07/16/2008 | CN101223146A Modulators of ATP-binding cassette transporters |
| 07/16/2008 | CN101223143A 3-cyanoquinoline inhibitors of TPL2 kinase and methods of making and using the same |
| 07/16/2008 | CN101223142A Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 07/16/2008 | CN101223141A Certain substituted amides, method of making, and method of use thereof |
| 07/16/2008 | CN101223140A Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |